Room temperature X-ray crystallography reveals oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL Mpro: Insights for enzyme mechanism and drug design

Room temperature X-ray crystallography reveals oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL Mpro: Insights for enzyme mechanism and drug design — Фото 2 из 13

Room temperature X-ray crystallography reveals oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL Mpro: Insights for enzyme mechanism and drug design — Фото 3 из 13

Room temperature X-ray crystallography reveals oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL Mpro: Insights for enzyme mechanism and drug design — Фото 4 из 13

Room temperature X-ray crystallography reveals oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL Mpro: Insights for enzyme mechanism and drug design — Фото 5 из 13

Room temperature X-ray crystallography reveals oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL Mpro: Insights for enzyme mechanism and drug design — Фото 6 из 13

Room temperature X-ray crystallography reveals oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL Mpro: Insights for enzyme mechanism and drug design — Фото 7 из 13

Room temperature X-ray crystallography reveals oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL Mpro: Insights for enzyme mechanism and drug design — Фото 8 из 13

Room temperature X-ray crystallography reveals oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL Mpro: Insights for enzyme mechanism and drug design — Фото 9 из 13

Room temperature X-ray crystallography reveals oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL Mpro: Insights for enzyme mechanism and drug design — Фото 10 из 13

Room temperature X-ray crystallography reveals oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL Mpro: Insights for enzyme mechanism and drug design — Фото 11 из 13

Room temperature X-ray crystallography reveals oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL Mpro: Insights for enzyme mechanism and drug design — Фото 12 из 13

Room temperature X-ray crystallography reveals oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL Mpro: Insights for enzyme mechanism and drug design — Фото 13 из 13

3D-модель · NIH 3D

Room temperature X-ray crystallography reveals oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL Mpro: Insights for enzyme mechanism and drug design

Площадка: NIH 3D
Цена: Бесплатно
Лицензия: CC-BY; Можно печатать, изменять и использовать в коммерции — с указанием автора.
Форматы: WRLGLBX3DSTL

18 Загрузки
261 Просмотры

Автор:cruzp2

Опубликована 07.12.2020

Скачать на

Описание

PDB Classifiation: VIRAL PROTEIN, HYDROLASE

Теги

viral protein hydrolase sars-cov-2 covid-19 sars-cov2 main protease escherichia coli molrep aimless crysalispro phenix 1.18.1_3865

Ещё по теме

Похожие модели

Бесплатно

Room-temperature X-ray Crystal structure of SARS-CoV-2 main protease in complex with Leupeptin

Room-temperature X-ray Crystal structure of SARS-CoV-2 main protease in complex with Leupeptin

NIH 3D · cruzp2

Бесплатно

Structural Plasticity of the SARS-CoV-2 3CL Mpro Active Site Cavity Revealed by Room Temperature X-ray Crystallography

Structural Plasticity of the SARS-CoV-2 3CL Mpro Active Site Cavity Revealed by Room Temperature X-ray Crystallography

NIH 3D · cruzp2

Бесплатно

X-ray Structure of SARS-CoV-2 main protease bound to Boceprevir at 1.45 A

X-ray Structure of SARS-CoV-2 main protease bound to Boceprevir at 1.45 A

NIH 3D · cruzp2

Бесплатно

Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication

Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication

NIH 3D · cruzp2

Бесплатно

Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor UAW248

Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor UAW248

NIH 3D · cruzp2

Бесплатно

Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor UAW247

Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor UAW247

NIH 3D · cruzp2

Бесплатно

Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with EY6A Fab

Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with EY6A Fab

NIH 3D · cruzp2

Бесплатно

Crystal Structure of NendoU (Uridylate-specific endoribonuclease, nsp15) from Betacoronavirus SARS-CoV-2

Crystal Structure of NendoU (Uridylate-specific endoribonuclease, nsp15) from Betacoronavirus SARS-CoV-2

NIH 3D · cruzp2

Бесплатно

Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor UAW246

Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor UAW246

NIH 3D · cruzp2

Бесплатно

SARS-CoV-2 main protease with unliganded active site (2019-nCoV, coronavirus disease 2019, COVID-19)

SARS-CoV-2 main protease with unliganded active site (2019-nCoV, coronavirus disease 2019, COVID-19)

NIH 3D · cruzp2

Бесплатно

Crystals Structure of the SARS-CoV-2 (COVID-19) main protease with inhibitor GC-376

Crystals Structure of the SARS-CoV-2 (COVID-19) main protease with inhibitor GC-376

NIH 3D · cruzp2

Бесплатно

Structure of SARS-CoV-2 ORF8 accessory protein

Structure of SARS-CoV-2 ORF8 accessory protein

NIH 3D · Meghan McCarthy

Названия используются только для указания источника результата. Polyzon не аффилирован с перечисленными площадками.